Group | Genotype | Plasma AUC Ratio | Urine AUC Ratio |
---|---|---|---|
Control | Reference Sequence(GG/CC) | 1.24 (0.46, 10) | 51.00 (55.19, 10) |
CYP2C19*2(GA/CC) | 0.63 (0.20, 3) | 8.56 (9.25, 3) | |
CYP2C19*17(GG/CT) | 0.54 (0.47, 2) | 43.54 (38.39, 2) | |
CYP2C19*17(GG/TT) | 0.87 (NA, 1) | 17.14 (NA, 1) | |
CYP2C19*2&CYP2C19*17(GA/CT) | 1.64 (NA, 1) | 26.18 (NA, 1) | |
Steatosis | Reference Sequence(GG/CC) | 0.55 (0.51, 5) | 38.05 (37.71, 6) |
CYP2C19*2(GA/CC) | 0.49 (N/A, 1) | 49.46 (NA, 1) | |
NASH | Reference Sequence(GG/CC) | 0.24 (0.19, 4) | 17.51 (17.02, 4) |
CYP2C19*17(GG/CT) | 1.97 (NA, 1) | 23.45 (NA, 1) |
NA, not applicable.